Home

Ingovány Kritikai Ragadós hepatic steatosis as a marker of metabolic dysfunction munkás törékeny társadalom

Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology
Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology

Role of hepatic fatty acid metabolism in the development of hepatic... |  Download Scientific Diagram
Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram

A human pluripotent stem cell model for the analysis of metabolic  dysfunction in hepatic steatosis - ScienceDirect
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect

Nonalcoholic fatty liver disease is an early predictor of metabolic  diseases in a metabolically healthy population | PLOS ONE
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population | PLOS ONE

Immune cell-mediated features of non-alcoholic steatohepatitis | Nature  Reviews Immunology
Immune cell-mediated features of non-alcoholic steatohepatitis | Nature Reviews Immunology

Thrombospondin 1 improves hepatic steatosis in diet-induced  insulin-resistant mice and is associated with hepatic fat content in humans  - eBioMedicine
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine

Immunological mechanisms and therapeutic targets of fatty liver diseases |  Cellular & Molecular Immunology
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology

Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and  Treatment
Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment

Defining paediatric metabolic (dysfunction)-associated fatty liver disease:  an international expert consensus statement - The Lancet Gastroenterology &  Hepatology
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology

IJMS | Free Full-Text | Metabolic Dysfunction-Associated Fatty Liver  Disease (MAFLD)—A Condition Associated with Heightened Sympathetic  Activation
IJMS | Free Full-Text | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation

Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin  Resistance and Type 2 Diabetes
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

A simplified flowchart from the radiologist's perspective that... |  Download Scientific Diagram
A simplified flowchart from the radiologist's perspective that... | Download Scientific Diagram

The diagnostic conundrum in non-alcoholic fatty liver disease
The diagnostic conundrum in non-alcoholic fatty liver disease

PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction
PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological  mechanisms shared between the two faces of the same coin
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver  Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Diagnostic and interventional circulating biomarkers in nonalcoholic  steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism -  Wiley Online Library
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

Links between metabolic syndrome and metabolic dysfunction-associated fatty  liver disease: Trends in Endocrinology & Metabolism
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes |  Diabetology & Metabolic Syndrome | Full Text
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text

A problem of proportions: estimates of metabolic associated fatty liver  disease and liver fibrosis in Australian adults in the nationwide 2012  AusDiab Study | Scientific Reports
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports

Non-alcoholic fatty liver disease: the interplay between metabolism,  microbes and immunity | Nature Metabolism
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism

JCI - Parental metabolic syndrome epigenetically reprograms offspring  hepatic lipid metabolism in mice
JCI - Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice

Antioxidants | Free Full-Text | Mechanisms of Non-Alcoholic Fatty Liver  Disease in the Metabolic Syndrome. A Narrative Review
Antioxidants | Free Full-Text | Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review

CRISPR-mediated BMP9 ablation promotes liver steatosis via the  down-regulation of PPARα expression | Science Advances
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances

Association of metabolic dysfunction-associated fatty liver disease with  kidney disease | Nature Reviews Nephrology
Association of metabolic dysfunction-associated fatty liver disease with kidney disease | Nature Reviews Nephrology

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic  syndrome - The Lancet Diabetes & Endocrinology
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome - The Lancet Diabetes & Endocrinology